Class II
Terminated
Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufact…
Why: Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.
- Company
- Teva Pharmaceuticals USA
North Wales, PA, United States - Reported
- Feb 22, 2017
- Recall started
- Feb 2, 2017
- Ended
- Feb 6, 2018
- Where sold
- Nationwide in the United States
- Amount
- 17,473 cartons
- Full product description
- Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.
- Lots / codes affected
- Lot # 33809881A, Exp 05/17; 33811151A, Exp 08/17
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.